Related Experiment Videos
Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells
1Department of Urology, Mayo Clinic/Foundation, Rochester, MN 55905, USA.
Abstract:
Although it has been shown that calpains may play a positive role in causing apoptosis of T cells, we report here that, on the contrary, the inhibition of calpain-like activities can induce apoptosis in human prostate cancer cells. Two calpain inhibitors were used to test growth response on prostate cancer cells and showed remarkable cytotoxicity. The cytotoxicity was due to apoptosis as judged by large genomic DNA fragmentation, chromatin condensation and nuclear fragmentation. Furthermore, using gel band shift assays we have demonstrated that calpain inhibitor 1 causes a prolonged elevation of AP-1 protein activity in human prostate cancer cells. The elevation of AP-1 activity appears to be specific, because calpain inhibitor 1 only stimulates AP-1 but not AP-2 and SP-1 activities. We postulate that the sustained increase in AP-1 activity may be involved in apoptosis induced in prostate cells by calpain inhibitors. Our study thus suggests that calpain-like activity may be a potentially therapeutic target for cancer.
Insights
Inhibition of calpain-like activity induces apoptosis in human prostate cancer cells, suggesting calpain as a novel cancer therapeutic target. This research highlights a new approach for prostate cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Calpains are implicated in T-cell apoptosis.
- The role of calpains in prostate cancer apoptosis is not well understood.
Purpose of the Study:
- To investigate the effect of calpain inhibition on human prostate cancer cells.
- To explore the underlying mechanisms of calpain inhibitor-induced apoptosis.
Main Methods:
- Treatment of prostate cancer cells with two calpain inhibitors.
- Assessment of cytotoxicity via DNA fragmentation, chromatin condensation, and nuclear fragmentation.
- Gel band shift assays to evaluate transcription factor activity (AP-1, AP-2, SP-1).
Main Results:
- Calpain inhibitors demonstrated significant cytotoxicity against prostate cancer cells.
- Cytotoxicity was confirmed to be apoptosis-induced.
- Calpain inhibitor 1 specifically and persistently elevated Activator Protein-1 (AP-1) activity.
Conclusions:
- Calpain inhibition induces apoptosis in human prostate cancer cells.
- Sustained AP-1 activation may mediate this apoptosis.
- Calpain-like activity represents a potential therapeutic target for prostate cancer.